Co-Inhibition of the Immunoproteasome Subunits LMP2 and LMP7 Ameliorates Immune Thrombocytopenia

6Citations
Citations of this article
12Readers
Mendeley users who have this article in their library.

Abstract

The immunoproteasome, a special isoform of the 20S proteasome, is expressed when the cells receive an inflammatory signal. Immunoproteasome inhibition proved efficacy in the treatment of autoimmune diseases. However, the role of the immunoproteasome in the pathogenesis of immune thrombocytopenia (ITP) remains unknown. We found that the expression of the immunoproteasome catalytic subunit, large multifunctional protease 2 (LMP2), was significantly upregulated in peripheral blood mononuclear cells of active ITP patients compared to those of healthy controls. No significant differences in LMP7 expression were observed between patients and controls. ML604440, an specific LMP2 inhibitor, had no significant impact on the platelet count of ITP mice, while ONX-0914 (an inhibitor of both LMP2 and LMP7) increased the number of platelets. In vitro assays revealed that ONX-0914 decreased the expression of FcγRI in ITP mice and decreased that of FcγRIII in ITP patients, inhibited the activation of CD4+ T cells, and affected the differentiation of Th1 cells in patients with ITP. These results suggest that the inhibition of immunoproteasome is a potential therapeutic approach for ITP patients.

References Powered by Scopus

Standardization of terminology, definitions and outcome criteria in immune thrombocytopenic purpura of adults and children: Report from an international working group

2162Citations
N/AReaders
Get full text

A draft map of the human proteome

1740Citations
N/AReaders
Get full text

A selective inhibitor of the immunoproteasome subunit LMP7 blocks cytokine production and attenuates progression of experimental arthritis

492Citations
N/AReaders
Get full text

Cited by Powered by Scopus

On the role of the immunoproteasome in protein homeostasis

36Citations
N/AReaders
Get full text

A nut for every bolt: Subunit-selective inhibitors of the immunoproteasome and their therapeutic potential

18Citations
N/AReaders
Get full text

A bibliometric analysis of primary immune thrombocytopenia from 2011 to 2021

10Citations
N/AReaders
Get full text

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Cite

CITATION STYLE

APA

Du, S. H., Xiang, Y. J., Liu, L., Nie, M., Hou, Y., Wang, L., … Shi, Y. (2021). Co-Inhibition of the Immunoproteasome Subunits LMP2 and LMP7 Ameliorates Immune Thrombocytopenia. Frontiers in Immunology, 11. https://doi.org/10.3389/fimmu.2020.603278

Readers over time

‘21‘22‘23‘2502468

Readers' Seniority

Tooltip

Researcher 3

60%

PhD / Post grad / Masters / Doc 2

40%

Readers' Discipline

Tooltip

Medicine and Dentistry 2

33%

Biochemistry, Genetics and Molecular Bi... 2

33%

Arts and Humanities 1

17%

Environmental Science 1

17%

Save time finding and organizing research with Mendeley

Sign up for free
0